Egypt’s Drug Authority (EDA) has ordered a Class II recall of one batch of Epikavit 10mg/ml ampoules, manufactured by the Egyptian International Pharmaceutical Industries Company (EIPICO), after EDA laboratories found the batch non-conforming to specification.
Distributors, pharmacies and health facilities must stop circulation of the batch, seize it and place it under quarantine. The recall applies only to the batch identified and not to circulation of the product generally. With an expiry of 31 January 2028, more than a year of shelf life remains.
| Product | Batch | Expiry | Manufacturer |
|---|---|---|---|
| Epikavit 10mg/ml ampoules | 2500865 | 31 January 2028 | Egyptian International Pharmaceutical Industries Company (EIPICO) |
Source: Egyptian Drug Authority (EDA), Report No. (101) for 2026, November 2026: https://www.edaegypt.gov.eg/media/xjuc5jgs/2340-epikavit.pdf